Mycophenolate mofetil
- PDF / 169,053 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 70 Downloads / 200 Views
1 S
Mycophenolate mofetil embryopathy following in utero exposure : case report In a study, 184 live births from singleton pregnancies in 145 women were evaluated, of whom, a neonate [age and sex not stated] was described, who developed mycophenolate mofetil embryopathy following in-utero exposure of mycophenolate mofetil. The neonate’s mother had a history of systemic lupus erythematosus and became pregnant. During pregnancy, she started receiving hydroxychloroquine and mycophenolate mofetil [dosages not stated]. However, a child was born with mycophenolate mofetil embryopathy [outcome not stated] following maternal exposure of mycophenolate mofetil during pregnancy. Haase I, et al. Safety and beneficial effects of hydroxychloroquine on pregnancy outcomes in women with systemic lupus erythematosus. Annals of the Rheumatic Diseases 79 803516273 (Suppl.): 1486 abstr. AB0375, Jun 2020. Available from: URL: https://ard.bmj.com/content/79/Suppl_1/1487.1 [abstract]
0114-9954/20/1831-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 21 Nov 2020 No. 1831
Data Loading...
